Michael A Smith's most recent trade in Insmed Inc was a trade of 1,396 Common Stock done at an average price of $173.3 . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 173.33 per share. | 06 Jan 2026 | 1,396 | 58,799 (0%) | 0% | 173.3 | 241,969 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 174.17 per share. | 06 Jan 2026 | 1,053 | 57,037 (0%) | 0% | 174.2 | 183,401 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 175.07 per share. | 06 Jan 2026 | 709 | 58,090 (0%) | 0% | 175.1 | 124,125 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 27,600 | 27,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 5,293 | 60,195 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.75 per share. | 03 Nov 2025 | 27,130 | 82,032 (0%) | 0% | 23.8 | 644,338 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 27,130 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.88 per share. | 03 Nov 2025 | 7,619 | 73,071 (0%) | 0% | 181.9 | 1,385,744 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 182.60 per share. | 03 Nov 2025 | 4,286 | 68,785 (0%) | 0% | 182.6 | 782,624 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 183.92 per share. | 03 Nov 2025 | 4,032 | 64,753 (0%) | 0% | 183.9 | 741,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 185.93 per share. | 03 Nov 2025 | 3,636 | 57,874 (0%) | 0% | 185.9 | 676,041 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 184.91 per share. | 03 Nov 2025 | 3,243 | 61,510 (0%) | 0% | 184.9 | 599,663 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.15 per share. | 03 Nov 2025 | 1,572 | 56,302 (0%) | 0% | 187.2 | 294,200 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.97 per share. | 03 Nov 2025 | 1,400 | 54,902 (0%) | 0% | 188.0 | 263,158 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.01 per share. | 03 Nov 2025 | 1,342 | 80,690 (0%) | 0% | 181.0 | 242,915 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 12,780 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 02 Sep 2025 | 12,780 | 79,174 (0%) | 0% | 30.5 | 389,279 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.16 per share. | 02 Sep 2025 | 8,300 | 61,029 (0%) | 0% | 144.2 | 1,196,528 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 143.16 per share. | 02 Sep 2025 | 7,391 | 69,329 (0%) | 0% | 143.2 | 1,058,096 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.18 per share. | 02 Sep 2025 | 4,944 | 56,085 (0%) | 0% | 145.2 | 717,770 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.16 per share. | 02 Sep 2025 | 1,354 | 77,820 (0%) | 0% | 141.2 | 191,131 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.89 per share. | 02 Sep 2025 | 1,183 | 54,902 (0%) | 0% | 145.9 | 172,588 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.06 per share. | 02 Sep 2025 | 1,100 | 76,720 (0%) | 0% | 142.1 | 156,266 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 11 Jul 2025 | 933 | 66,394 (0%) | 0% | 102.5 | 95,642 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.41 per share. | 11 Jul 2025 | 748 | 67,327 (0%) | 0% | 96.4 | 72,115 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.50 per share. | 05 Jun 2025 | 1,879 | 67,718 (0%) | 0% | 73.5 | 138,107 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 03 Jun 2025 | 1,448 | 69,597 (0%) | 0% | 71.5 | 103,532 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 30 May 2025 | 20,000 | 71,045 (0%) | 0% | 70 | 1,400,000 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 30 May 2025 | 6,327 | 91,045 (0%) | 0% | 68.6 | 433,779 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 27,100 | 27,100 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,578 | 97,372 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 67.81 per share. | 13 May 2025 | 4,407 | 92,203 (0%) | 0% | 67.8 | 298,839 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 65.61 per share. | 13 May 2025 | 409 | 91,794 (0%) | 0% | 65.6 | 26,834 | Common Stock |
| Zebra Tech (Class A) | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 265.37 per share. | 08 May 2025 | 830 | 10,695 (0%) | 0% | 265.4 | 220,257 | Class A Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 47,295 | 117,260 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 80.90 per share. | 05 Feb 2025 | 20,650 | 96,610 (0%) | 0% | 80.9 | 1,670,585 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.16 per share. | 13 Sep 2024 | 18,871 | 76,856 (0%) | 0% | 74.2 | 1,399,473 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.75 per share. | 13 Sep 2024 | 9,000 | 67,856 (0%) | 0% | 74.8 | 672,750 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.76 per share. | 13 Sep 2024 | 7,000 | 95,727 (0%) | 0% | 22.8 | 159,320 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 72.75 per share. | 12 Aug 2024 | 67,655 | 109,142 (0%) | 0% | 72.7 | 4,921,901 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 41,640 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.91 per share. | 12 Aug 2024 | 41,640 | 142,267 (0%) | 0% | 13.9 | 579,212 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 34,530 | 34,530 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 12 Aug 2024 | 34,530 | 176,797 (0%) | 0% | 17.1 | 589,427 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.65 per share. | 12 Aug 2024 | 20,415 | 88,727 (0%) | 0% | 73.7 | 1,503,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 11,900 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 12 Aug 2024 | 11,900 | 100,627 (0%) | 0% | 17.2 | 204,204 | Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 120,331 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.44 per share. | 05 Aug 2024 | 22,523 | 97,808 (0%) | 0% | 21.4 | 482,893 | Class A Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.05 per share. | 08 Jul 2024 | 730 | 88,727 (0%) | 0% | 70.1 | 51,137 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 28 May 2024 | 44,722 | 88,828 (0%) | 0% | 49.5 | 2,215,081 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 14,810 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.67 per share. | 28 May 2024 | 14,810 | 133,550 (0%) | 0% | 13.7 | 202,453 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.16 per share. | 28 May 2024 | 10,000 | 111,579 (0%) | 0% | 16.2 | 161,600 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.07 per share. | 28 May 2024 | 7,000 | 101,579 (0%) | 0% | 16.1 | 112,490 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,691 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 28 May 2024 | 3,691 | 115,270 (0%) | 0% | 10.8 | 40,047 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,470 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.38 per share. | 28 May 2024 | 3,470 | 118,740 (0%) | 0% | 11.4 | 39,489 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 65,230 | 65,230 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,308 | 99,672 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.40 per share. | 13 May 2024 | 5,093 | 94,579 (0%) | 0% | 25.4 | 129,362 | Common Stock |
| Zebra Tech (Class A) | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 316.50 per share. | 09 May 2024 | 696 | 9,865 (0%) | 0% | 316.5 | 220,284 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 6,250 | 73,153 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.58 per share. | 07 May 2024 | 2,822 | 70,331 (0%) | 0% | 17.6 | 49,611 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 1,581 | 67,617 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 1,581 | 0 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.57 per share. | 12 Mar 2024 | 714 | 66,903 (0%) | 0% | 16.6 | 11,831 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 47,835 | 47,835 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 17,241 | 71,235 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 17,241 | 51,725 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.37 per share. | 01 Mar 2024 | 5,199 | 66,036 (0%) | 0% | 17.4 | 90,307 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,753 | 1,753 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,753 | 54,523 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.37 per share. | 01 Mar 2024 | 529 | 53,994 (0%) | 0% | 17.4 | 9,189 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael Smith A | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 5,953 | 54,696 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Smith Michael A | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2024 | 5,953 | 11,905 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael Smith A | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.28 per share. | 25 Feb 2024 | 1,926 | 52,770 (0%) | 0% | 18.3 | 35,207 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2023 | 3,877 | 0 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2023 | 3,877 | 50,502 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.61 per share. | 28 May 2023 | 1,759 | 48,743 (0%) | 0% | 12.6 | 22,181 | Class A Common Stock |
| Zebra Tech (Class A) | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 265.28 per share. | 11 May 2023 | 830 | 9,169 (0%) | 0% | 265.3 | 220,182 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 6,250 | 12,500 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 6,250 | 49,460 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.85 per share. | 07 May 2023 | 2,835 | 46,625 (0%) | 0% | 11.9 | 33,595 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 1,580 | 1,581 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 1,580 | 43,690 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.13 per share. | 12 Mar 2023 | 480 | 43,210 (0%) | 0% | 11.1 | 5,342 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 68,966 | 68,966 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,753 | 42,994 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,753 | 3,506 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.18 per share. | 01 Mar 2023 | 884 | 42,110 (0%) | 0% | 10.2 | 8,999 | Class A Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 5,952 | 44,107 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 5,952 | 17,858 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.90 per share. | 25 Feb 2023 | 2,866 | 41,241 (0%) | 0% | 9.9 | 28,373 | Class A Common Stock |